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Abstract: BACKGROUND Evaluation of core needle biopsies (CNB) is a standard procedure for the
diagnosis of breast cancer. However, tissue processing and image preparation is a time- consuming
procedure and instant on-site availability of high-quality images could substantially improve the efficacy
of the diagnostic procedure. Conventional microscopic methods, such as frozen section analysis (FSA)
for detection of malignant cells still have clear disadvantages. In the present study, we tested a confocal
microscopy scanner on fresh tissue from CNB with intention to develop an alternative device to FSA in
clinical practice. PATIENTS AND METHODS In 24 patients with suspicious breast lesions standard of
care image-guided biopsies were performed. Confocal images have been obtained using the Histolog™
Scanner and evaluated by two independent pathologists. Hematoxylin-Eosin (HE) histological sections of
the biopsies were routinely processed in a blinded fashion with respect to the confocal images. RESULTS
In total 42 confocal images were generated from 24 biopsy specimens, and available for analysis within
a few minutes of taking the biopsy. This resulted in 2 × 42 = 84 pathologic evaluations. In four cases,
a pathologic diagnosis was not possible with confocal microscopy. An exact correlation based on the
B-classification was reached in 41 out of 80 examinations and in another 35 cases in a broader sense of
correspondence definition (i.e. malignant vs. benign). CONCLUSIONS As a reliable on-site method, the
Histolog™ Scanner provides a visualization of cellular details equivalent to the HE standards, permitting
rapid and accurate diagnosis of malignant and benign breast lesions. Furthermore, this device offers great
potential for immediate margin analysis of specimen in breast conserving therapy.
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Abstract
Background: Evaluation of core needle biopsies (CNB) is a standard procedure for the diagnosis of breast cancer.
However, tissue processing and image preparation is a time- consuming procedure and instant on-site availability
of high-quality images could substantially improve the efficacy of the diagnostic procedure. Conventional
microscopic methods, such as frozen section analysis (FSA) for detection of malignant cells still have clear
disadvantages. In the present study, we tested a confocal microscopy scanner on fresh tissue from CNB with
intention to develop an alternative device to FSA in clinical practice.
Patients and methods: In 24 patients with suspicious breast lesions standard of care image-guided biopsies were
performed. Confocal images have been obtained using the Histolog™ Scanner and evaluated by two independent
pathologists. Hematoxylin-Eosin (H&E) histological sections of the biopsies were routinely processed in a blinded
fashion with respect to the confocal images.
Results: In total 42 confocal images were generated from 24 biopsy specimens, and available for analysis within a
few minutes of taking the biopsy. This resulted in 2 × 42 = 84 pathologic evaluations. In four cases, a pathologic
diagnosis was not possible with confocal microscopy. An exact correlation based on the B-classification was
reached in 41 out of 80 examinations and in another 35 cases in a broader sense of correspondence definition
(i.e. malignant vs. benign).
Conclusions: As a reliable on-site method, the Histolog™ Scanner provides a visualization of cellular details
equivalent to the H&E standards, permitting rapid and accurate diagnosis of malignant and benign breast lesions.
Furthermore, this device offers great potential for immediate margin analysis of specimen in breast conserving
therapy.
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Background
Image-guided biopsy is a well-established clinical pro-
cedure for the diagnosis of breast abnormalities [1].
Suspicious lesions within the tissue are correlated with
the histological result of the biopsy specimen. Interpret-
ation is critically dependent on the experience of the
radiologist and pathologist, quality of the specimen, and
artefacts of the fixation and dyeing process [2]. Clinical
infrastructure impacts time to diagnosis which may lead
to an emotional burden for the patient and delay the
initiation of the therapy. If the biopsy specimen does not
contain the suspect lesion, it increases the risk of misin-
terpretation. A routine on-site, easy to use histological
evaluation of core needle biopsies has not yet been
established. Correlation of clinical and histological image
would allow an immediate feedback, and could fasten
the turnaround time for tissue biopsies.
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In the intra-operative setting, the need for a fast and
reliable on-site histological evaluation of breast malig-
nancies is widely acknowledged. Because clear margins
are mandatory in breast-conserving surgery [3], surgeons
face the dilemma of whether to generate a minimal
defect within the breast while performing a precise
tumor excision, or to make a wider excision and reduce
the cosmetic results [4]. However, in some types of
breast cancer, intraoperative assessment of margins is
difficult to perform [5, 6]. Intraoperative frozen section
analysis (FSA) is the standard microscopic method for
margin assessment. This approach clearly has limitations
[7, 8] and only investigates the shortest distance from
the tumor perpendicular to the margin instead of the
surface of the specimen.
In search for alternative methods for rapid intraopera-
tive evaluation of tumor margins, some approaches for
high resolution imaging have been recently investigated.
Full field Optical Coherence Tomography (FF-OCT),
which provides sub-surface images of tissue with a high
resolution has been a topic of selected studies [9, 10].
However, practicability in clinical settings is limited, be-
cause interpretation of the pictures requires specific
training of the pathologist. Tao et al. used nonlinear
microscopy (NLM) to recently demonstrate a method
with high diagnostic accuracy and sensitivity [11]. So far
fluorescence-based confocal microscopy has shown
promising results in evaluating tissue morphology of a
specimen [12–14]. The limited field of view is however
not suited to cover large surgical specimen surfaces
while the process of “mosaicking” multiple small images
is time consuming and may impact accuracy [12].
Recently a confocal laser microscopy scanner became
available for evaluation. In the present study, we tested
the Histolog™ Scanner (HS) to evaluate the device for
application in clinical practice. The technique uses a
confocal microscope and allows observation of the tissue
in a spectrum between gross morphology and a sub-
cellular level that approaches the resolution of a regular
5x objective. Histological images of the superficial layers
of fresh thick tissue can be generated for a scanning area
of 2.5 cm2 by a unique raster. HS was recently tested in
a clinical study on skin cancer specimens with encour-
aging results [15].
Similarly to the intraoperative situation, quality and
reliability of diagnosis with image guided biopsies relies
on the quality of the technique, and experience of the
performing clinician and the pathologist. The aim of our
investigation was to assess image quality and correct
diagnosis of human breast cancer tissue in core needle
biopsies by using the HS, and to further evaluate the
practicability and reliability of the device. For this
purpose, two independent experienced pathologists read
and interpreted the images obtained with the HS
scanner and the images obtained after digitalisation of
the routinely processed core biopsies.
Methods
The primary endpoint was to evaluate the correspond-
ence of breast cancer diagnosis between assessment of
confocal HS images and gold standard histological
images.
Patients and specimens
We examined 23 ultrasound guided core needle biopsies
and one tomosynthesis guided vacuum biopsy, adding
up to 24 cases of breast tumors which presented as
suspicious for cancer in female patients.
After examination of the patient by a consultant med-
ical doctor and sonographic or mammographic detection
of a breast lesion suspicious for breast cancer, a biopsy
with two samples was taken to confirm the diagnosis
histologically. Taking two or more biopsy samples from
a suspicious lesion is established in the clinical routine
for sensitivity improvement. General informed consent
was obtained from each patient before any diagnostic
procedure was initiated.
On-side procedure
After taking biopsy samples from a suspicious lesion of
the breast, the fresh biopsy specimen was immediately
processed for HS imaging. Before imaging, the sample
was incubated for 30 s in Acridine Orange solution
0.01% (Remel, ThermoFisher), and rinsed in 0.9% NaCl
solution to remove excess dye. The specimen was then
ready for imaging procedure, which provided a preview
and a maximum-resolution picture.
After taking the scanner pictures the specimen was
processed for the control procedure, i.e. it was fixed in
4% buffered formalin and underwent subsequent paraffin
embedding after transfer to the Institute of Pathology
and Molecular Pathology (Fig. 1). Control H&E stained
histological slides as well as other ancillary techniques as
immunohistochemistry and in-situ hybridisation (as
fluorescent labelled FISH probes) were prepared for
standard of care analysis by the local pathologist and fi-
nally a histological diagnosis was defined for patient’s
continuous care. Images obtained with the HS have not
been used in the present study to determine the final
histological diagnosis.
Staining, equipment and image acquisition
Staining was performed with Acridine Orange solution
0.01%, a topical fluorescent dye approved for medical
use which stains nuclei and does not interact with
subsequent control H&E process.
Imaging of the biopsies was performed using a fresh
tissue confocal laser scanner designed for use in a
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medical setting (Histolog™ Scanner v1 device from
SamanTree Medical SA, Lausanne, Switzerland). The de-
vice integrates a computer with an image display moni-
tor and relies on the imaging of laser scanning confocal
fluorescence microscopy. Fluorescence is excited by a
laser diode at the wavelength of 488 nm and fluores-
cence emission is collected in the wavelength above 500
nm. The HS images cover an area of 16 × 16mm, corre-
sponding to 2.5 cm2 at once and provides seamless im-
ages without additional post-processing.
A fast image mode (preview) provided an image of
1600 × 1600 pixels within 5 s and a second mode (acquire)
offered a maximum-resolution image of 8000 × 8000
pixels within 50 s. The fluorescence images were displayed
with an artificial coloring of the grey values, resembling
the result of a standard mono reagent such as Toluidine
Blue (Figs. 2 and 3). After creating the preview and the
acquired image from one side, the specimen was turned
upside down and the imaging procedure was repeated.
The preview images served to check whether all tissue is
included in the image, and the image obtained in the
acquire mode was the one with maximum resolution used
for histopathologic evaluation.
Imaging and pathological assessment
Two pathologists from different centers independently
evaluated the two HS acquire mode images of every
specimen. Corresponding H&E stained histological slides
(i.e. the gold standard pathological assessment for breast
core biopsies) were digitalized using a digital pathology
system (scanned via Hamamatsu NanoZoomer2.0 HAT
C9600 series and displayed via Software Leica Digital
Image Hub) and assessed blinded some days afterwards,
either at the microscope or from the screen. High-
qualitative digital images of H&E stained slides are
routinely used by the study pathologists. The evaluation
results from both HS images as well as those from the
standard histology were allocated to one of the different
categories of breast cancer detection correspondent to
the B-Classification as an established reporting system
for minimal invasive biopsies (0: No diagnosis possible;
1: Normal tissue; 2: Benign lesion; 3: Indeterminate; 4:
Suspicious of malignancy; 5: Malignancy) [16].
Measurement point
A correspondence between both methods’ assessments
of breast cancer structures was established by the
pathologists after the classification of HS obtained
images and gold standard images.
Correspondence was confirmed in cases where histo-
logical diagnosis was allocated to the same category
(narrow-sense correspondence, NSC) or at least to the
nearest lower B- classification (broad-sense correspond-
ence, BSC), i.e. broad-sense correspondence was assigned
for categories B2 and B3, as well as for categories B4 and
B5. Correspondence was denied (NO) in case of divergent
categories. Correspondence could not be determined
(ND) in cases that did not allow the establishment of a
diagnosis (Tables 1 and 2).
Statistics
κ-value was calculated by SISA Binominal online tool [17].
Ethical and regulatory considerations
The study was conducted following the protocol ap-
proved by the Cantonal Ethics Committee of Zurich
(BASEC-Nr. 2017–00863) and in accordance with Good
Clinical Practice Guidelines. Participants granted a
written consent to participate.
Results
Correspondence of diagnoses & image performance
Two pictures in the acquired HS mode were obtained
for 18 specimens. In six samples, only one image was
suitable for analysis. In two cases, poor quality of the im-
ages led to the exclusion. Limited performing time was
the reason in four cases, e.g. if there were complications
in taking the biopsy. Time limitation was given because
tissue had to be finally fixed in formalin within 10 min.
The images were analyzed by two independent patholo-
gists yielding 84 diagnoses in total (Tables 1 and 2). In
Fig. 1 Schematic diagram of the on-site preparation and imaging
process with the HS
Elfgen et al. Diagnostic Pathology           (2019) 14:58 Page 3 of 8
Fig. 3 Zoomed details of the microscopic scanner images with artificial coloring of the grey values: normal breast tissue (left side) and invasive
carcinoma (right side)
Fig. 2 Human breast biopsy imaged with the HistologTM Scanner (left) and the corresponding H&E microscopy slide used for pathological final
assessment (right). Staining with a fluorescence dye was performed before on-site scanning. The images were displayed with an artificial coloring
of the grey values, which mimics an H&E stain and is adapted to the needs of the clinical users. The encircled areas indicate invasive breast
cancer location as detected by the pathologists in both images using the full resolution zooming feature to reveal morphological details
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80 cases, pathological diagnosis corresponded to the B-
classification. In four cases, pathological diagnosis was
not obtainable in the first image due to limited specimen
quality. After re-positioning the sparse tissue, the second
image allowed an adequate diagnosis except in one case.
The correspondence assessment resulted in a total of
76 correspondences (95%, Tables 1 and 2). Narrow sense
correspondence (NSC), or accordance, was found in 41
of 80 diagnoses (51%). Broad sense correspondence
(BSC) was assigned to 35 of 80 diagnoses (44%), reflect-
ing a correct identification of the benign or malignant
nature of the tumor, but the pathologists’ level of confi-
dence differed. Four mismatches (lack of correspond-
ence) occurred, one of them likely due to limited quality
of the specimen. The final gold-standard assessments
resulted in 20 diagnoses of invasive cancer, two
carcinoma-in-situ (DCIS) and two benign lesions.
Histological subtypes
In the final histopathological diagnosis, 13 biopsy speci-
mens were diagnosed as invasive carcinoma of no special
type (NST). In four cases, lobular invasive cancer was
diagnosed, in one specimen an invasive- apocrine carcin-
oma, one invasive- mucinous carcinoma, and one micro-
papillary carcinoma. DCIS and benign lesions were each
detected in two specimens. We recognized four mis-
matches in different cancer subtypes: two in lobular
invasive cancer, one in invasive- mucinous carcinoma,
and one in carcinoma of NST.
Time frame for tissue processing
Time to generate images of breast biopsy specimens,
followed by final fixation in formalin, was less than 10
min for all cases, thus guaranteeing tissue integrity for
further standard of care analysis according to patho-
logical guidelines [16]. Time for interpretation of HS im-
ages ranged between 8 s and 5min, which corresponded
to the required time frame for the final interpretation of
the digitized H&E slides.
Discussion
In the aim of finding a cost-effective and beneficial inter-
vention for fast evaluation of cancer cells, several on-site
techniques have been evaluated [9, 18]. However, weak
sensitivity and limited clinical practicability were the
main deficits so far [10, 19, 20]. Previous publications
documented a high image resolution by confocal micro-
scope scanning, providing a visualization of cellular de-
tails equal to H&E standard [13–15]. During the staining
process applying this technique, fluorochromes mainly
dye nuclei and intensify the contrast between epithelium
and stroma. As far as the evaluation, done by two
independent pathologists, of the two image modalities
can be interpreted, there was no detectable morphologic
Table 2 Results: correlation table of B-classification results
(B-classification from 1 = normal tissue to 5 =malignant)
Sample
No.
Pathologist A Pathologist B
Scanner images H&E slides Scanner images H&E slides
1 5 0 5 4 0 5
2 1 1 1 3 2 2
3 4 4 5 1 1 5
4 4 0 5 3 0 5
5 4 4 5 0 4 5
6 5 5 5 5 5 5
7 5 4 5 4 4 5
8 0 4 5 0 4 4
9 4 5 5 4 4 5
10 5 5 5 4 5 5
11 4 4 5 4 5 5
12 4 4 5 4 4 5
13 4 0 5 4 0 4
14 4 0 5 4 0 5
15 5 5 5 5 4 5
16 5 5 5 5 5 5
17 5 5 5 5 5 5
18 4 4 5 4 4 5
19 4 5 5 5 5 5
20 5 5 5 5 5 5
21 3 0 4 0 0 4
22 5 5 5 5 5 5
23 3 0 2 4 0 4
24 2 3 2 3 3 2
Mismatch is coloured black; 0 = could not be determined. κ-value for broad
sense correspondence = 0.61, substantial agreement; κ-value for narrow sense
correspondence = 0.43, moderate agreement
Table 1 Results: B-classification of Confocal scanner images
compared to B-classification of H&E images
Histolog™ Scanner Acquire Images





4 1 (ND) 11 (NO) 4
5 3 (ND) 2 (NO) 11 (NO) 30 33
(Broad sense correspondence; NO mismatch, ND could not be determined). In
most cases, one H&E image- based classification was compared to two HS
image-based classifications
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effect of the Acridin Orange incubation on the quality of
the histopathological sections (Figs. 4 and 5). In contrast
to conventional techniques, confocal microscopy uses
point illumination and a pinhole to exclude interfer-
ing signals out of the specimen focus. Malignant cells
with morphological characteristics of the nucleus can
be easily identified and distinguished from normal
glandular, adipose and stromal tissue. Digital coloring
facilitates the histopathological analysis, and conse-
quentially the learning curve for interpretation is
usually steep.
This report shows a promising approach to achieve
fast and on-site diagnosis of high quality images ob-
tained from the surface of fresh CNB. The method does
not interfere with the standard of care workflow and
therefore also has great potential to support surgical
margin assessment in breast conserving therapy. Using
this innovative approach, histology grade images from
the entire surface of the resection margins can be ob-
tained without loss of tissue due to freezing and cutting
artefacts. Furthermore, the subsequent procedure of fix-
ation, histologic and immunologic examination of the
specimen is not affected.
HS images eliminate the need for mosaicking of mul-
tiple images, and therefore misinterpretation caused by
gaps or overlapping can be excluded. In this study, pa-
thologists without previous training interpreted confocal
images without knowledge of the corresponding H&E
standard result. However, earlier reports also showed ac-
curate and reliable evaluation of confocal microscopy
images by surgeons [12]. Conformity of malignant or
non-malignant diagnosis was 95% for scanner images
compared to H&E standard and therefore proved to be
highly reliable.
Using traditional techniques of H&E staining, misin-
terpretations of tissue samples may occur mainly due
to tumor type, biopsy material and technical issues,
as well as due to pathologist’s experience [2]. Two of
our mismatches with the HS occurred in a case of
invasive lobular carcinoma, which is known to be
challenging in the H&E standard method, and often
requires additional techniques such as immunohisto-
chemistry [21, 22]. Misinterpretation of the lobular
cancer was seen in the analysis of pathologist A,
while pathologist B had a narrow sense correspond-
ence for these images. The other two mismatches
were found in cases where only one image of the
specimen was available to the pathologists.
Employing the HS scanning technique, this study
clearly demonstrates that quality monitoring of the bi-
opsy tissue on-site is reliable, which can reduce the rate
of false negative results or re-biopsies. As usually both
sides of the tissue sample are imaged, we also see an
advantage in that approach compared to the routine
histological examination.
With a high level of correspondence between two
independent pathologists, the present study demon-
strates that carcinoma of the breast can be diagnosed
with a high accuracy in biopsy specimen using HS
images.
Fig. 4 Pictures show the negligibly small effect of the preparation process for scanning on the final pathologic routine: On-site scanning
procedure does not interfere with the subsequent control H&E process. HE stains and high magnification histological appearance of two cases.
Case 22 (a/b): invasive ductal (NST) carcinoma. a HE stain, regular formalin fixation. b HE stain, formalin fixation after confocal microscopy. Case 23
(c/d): high grade DCIS c) HE stain, regular formalin fixation. d HE stain, formalin fixation after confocal microscopy
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Limitations
The presented study has some limitations. We analyzed
a limited number of cases, and included only highly sus-
picious lesions. Matched H&E stained slides were digita-
lized before evaluation. Further prospective studies are
underway to substantiate our results on a larger cohort
and variety of breast lesions and furthermore, to evalu-
ate performance of the device on surgical specimen.
Conclusion
The Histolog™ Scanner detects breast cancer in fresh hu-
man tissue with accuracy and high reliability. It is simple
to use, cost- and time-efficient and has a great potential
to be adopted for routine use in intra-operative margin
assessment.
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